LoQus23 is a startup based in the United States, 1 tracked investor.
LoQus23 is a startup based in the United States. Brouky records 1 investor associated with the company.
LoQus23 develops small molecule inhibitors targeting somatic expansion in DNA to treat Huntington’s Disease and other triplet repeat expansion neurodegenerative diseases by slowing DNA instability and neurodegeneration.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.